BACKGROUND: Very little direct evidence exists on use of corticosteroids in patients with
coronavirus disease 2019 (COVID-19). Indirect evidence from related conditions must …

Background Specific treatments for influenza are limited to neuraminidase inhibitors and
adamantanes. Corticosteroids show evidence of benefit in sepsis and related conditions …

Objectives: Corticosteroids may be beneficial in sepsis, but uncertainty remains over their
effects in severe influenza. This systematic review updates the current evidence regarding …

Objective: To determine the impact of adjuvant corticosteroids administered to patients
hospitalized with influenza A (H7N9) viral pneumonia. Design: The effects of adjuvant …

Background The effect of corticosteroids on influenza A (H1N1) pdm09 viral pneumonia
patients remains controversial, and the impact of dosage has never been studied. Methods …

Background. Most studies have reported that corticosteroid therapy adversely influences
influenza-related outcomes. Methods. Electronic databases were searched from inception to …

Influenza causes seasonal epidemics of respiratory infection in all parts of the world.
Manifestations of influenza range from mild upper to severe lower respiratory tract infection …

Background Current studies regarding glucocorticosteroid treatment of influenza have only
estimated risk of critical illness or death which can be easily confounded by timing of …

CONTEXTE: Il existe très peu de données directes sur l'administration de corticostéroïdes
aux patients atteints de la maladie à coronavirus 2019 (COVID-19). Les données indirectes …

En las últimas dos décadas se han presentado brotes de enfermedades infecciosas
emergentes, con impacto tanto en la población general como en la población obstétrica …